Literature DB >> 23060089

CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation.

P Ramirez, J E Wagner, T E Defor, C R Eide, J S Miller, D J Weisdorf, C G Brunstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23060089      PMCID： PMC3668782          DOI： 10.1038/leu.2012.261

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

Authors:  Junya Kanda; David A Rizzieri; Cristina Gasparetto; Gwynn D Long; John P Chute; Keith M Sullivan; Ashley Morris; Clayton A Smith; Donna E Hogge; Janet Nitta; Kevin Song; Donna Niedzwiecki; Nelson J Chao; Mitchell E Horwitz
Journal:  Biol Blood Marrow Transplant       Date:  2010-09-22       Impact factor: 5.742

2.  Cell adhesion molecule expression in cord blood CD34+ cells.

Authors:  F Timeus; N Crescenzio; G Basso; U Ramenghi; P Saracco; V Gabutti
Journal:  Stem Cells       Date:  1998       Impact factor: 6.277

Review 3.  How do stem cells find their way home?

Authors:  Tsvee Lapidot; Ayelet Dar; Orit Kollet
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

4.  Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation.

Authors:  Andromachi Scaradavou; Katherine M Smith; Rebecca Hawke; Allison Schaible; Michelle Abboud; Nancy A Kernan; James W Young; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-22       Impact factor: 5.742

5.  Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.

Authors:  Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Bruce R Blazar; Philip B McGlave; Jeffrey S Miller; Catherine M Verfaillie; John E Wagner
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

6.  Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation.

Authors:  Jonathan Hoggatt; Pratibha Singh; Janardhan Sampath; Louis M Pelus
Journal:  Blood       Date:  2009-03-26       Impact factor: 22.113

7.  Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

Authors:  Claudio G Brunstein; Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Jeffrey S Miller; Bruce R Blazar; Philip B McGlave; John E Wagner
Journal:  Blood       Date:  2007-06-14       Impact factor: 22.113

8.  Short-term culture of umbilical cord blood-derived CD34 cells enhances engraftment into NOD/SCID mice through increased CXCR4 expression.

Authors:  Norioki Ohno; Teruyuki Kajiume; Yasuhiko Sera; Takashi Sato; Masao Kobayashi
Journal:  Stem Cells Dev       Date:  2009-10       Impact factor: 3.272

Review 9.  Chemokines in hematopoiesis.

Authors:  Hal E Broxmeyer
Journal:  Curr Opin Hematol       Date:  2008-01       Impact factor: 3.284

10.  Factors predicting single-unit predominance after double umbilical cord blood transplantation.

Authors:  P Ramirez; J E Wagner; T E DeFor; B R Blazar; M R Verneris; J S Miller; D H McKenna; D J Weisdorf; P B McGlave; C G Brunstein
Journal:  Bone Marrow Transplant       Date:  2011-09-26       Impact factor: 5.483
View more
  4 in total

1.  Complement fragment 3a priming of umbilical cord blood progenitors: safety profile.

Authors:  Claudio G Brunstein; David H McKenna; Todd E DeFor; Darin Sumstad; Philip Paul; Daniel J Weisdorf; Mariusz Ratajczak; Mary J Laughlin; John E Wagner
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-25       Impact factor: 5.742

2.  Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation.

Authors:  Corey Cutler; Pratik Multani; David Robbins; Haesook T Kim; Thuy Le; Jonathan Hoggatt; Louis M Pelus; Caroline Desponts; Yi-Bin Chen; Betsy Rezner; Philippe Armand; John Koreth; Brett Glotzbecker; Vincent T Ho; Edwin Alyea; Marlisa Isom; Grace Kao; Myriam Armant; Leslie Silberstein; Peirong Hu; Robert J Soiffer; David T Scadden; Jerome Ritz; Wolfram Goessling; Trista E North; John Mendlein; Karen Ballen; Leonard I Zon; Joseph H Antin; Daniel D Shoemaker
Journal:  Blood       Date:  2013-08-30       Impact factor: 22.113

3.  Thrombopoietin treatment of one graft in a double cord blood transplant provides early platelet recovery while contributing to long-term engraftment in NSG mice.

Authors:  Mark van der Garde; Yvette van Hensbergen; Anneke Brand; Manon C Slot; Alice de Graaf-Dijkstra; Arend Mulder; Suzanne M Watt; Jaap Jan Zwaginga
Journal:  Stem Cells Dev       Date:  2015-01-01       Impact factor: 3.272

4.  MiR-9 Controls Chemotactic Activity of Cord Blood CD34⁺ Cells by Repressing CXCR4 Expression.

Authors:  Tae Won Ha; Hyun Soo Kang; Tae-Hee Kim; Ji Hyun Kwon; Hyun Kyu Kim; Aeli Ryu; Hyeji Jeon; Jaeseok Han; Hal E Broxmeyer; Yongsung Hwang; Yun Kyung Lee; Man Ryul Lee
Journal:  Int J Stem Cells       Date:  2018-11-30       Impact factor: 2.500
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.